Which surgical approach is more favorable for pheochromocytoma of different sizes (< 6 cm vs. ≥ 6 cm)? A single retrospective center experience
- PMID: 37697366
- PMCID: PMC10494336
- DOI: 10.1186/s12957-023-03164-w
Which surgical approach is more favorable for pheochromocytoma of different sizes (< 6 cm vs. ≥ 6 cm)? A single retrospective center experience
Abstract
Background: To compare the surgical effects of lateral transperitoneal approach (LTA) and posterior retroperitoneal approach (PRA) for pheochromocytoma of different sizes.
Methods: Data on patients with pheochromocytoma from 2014 to 2023 were collected from our hospital. According to different surgical approaches and tumor size, all patients were divided into four groups: tumor size < 6 cm for LTA and PRA and tumor size ≥ 6 cm for LTA and PRA. We compared these two surgical methods for pheochromocytoma of different sizes.
Results: A total of 118 patients with pheochromocytoma underwent successful laparoscopic surgery, including PRA group (n = 80) and LTA group (n = 38). In tumor size < 6 cm, the outcomes were no significant difference in LTA and PRA. In tumor size ≥ 6 cm, there was a significant difference in operation time (214.7 ± 18.9 vs. 154.3 ± 8.2, P = 0.007) and intraoperative blood loss (616.4 ± 181.3 vs. 201.4 ± 45.8, P = 0.037) between LTA and PRA.
Conclusion: LTA and PRA were performed safely with similar operative outcomes in patients with pheochromocytoma size < 6 cm. While both LTA and PRA were executed with a commendable safety profile and comparable operative results in patients afflicted by pheochromocytomas < 6 cm, the PRA technique distinctly showcased advantages when addressing large-scale pheochromocytomas (≥ 6 cm). Notably, this manifested in reduced operative time, diminished intraoperative blood loss, decreased hospitalization expenses, and a paucity of procedural complications.
Keywords: Different sizes; Laparoscopic adrenalectomy; Lateral transperitoneal adrenalectomy; Pheochromocytoma; Posterior retroperitoneoscopic adrenalectomy.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
References
-
- Anyfanti P, Mastrogiannis Κ, Lazaridis Α, Tasios Κ, Vasilakou D, Kyriazidou Α, Aroutsidis F, Pavlidou O, Papoutsopoulou Ε, Tiritidou A, Kotsis V, Triantafyllou Α, Zarifis Ι, Douma S, Gkaliagkousi Ε. Clinical presentation and diagnostic evaluation of pheochromocytoma: case series and literature review. Clin Exp Hypertens. 2023;45(1):2132012. doi: 10.1080/10641963.2022.2132012. - DOI - PubMed
-
- Yang Y, Zhang J, Fang L, Jia X, Zhang W. Non-selective alpha-blockers provide more stable intraoperative hemodynamic control compared with selective alpha1-blockers in patients with pheochromocytoma and paraganglioma: a single-center retrospective cohort study with a propensity score-matched analysis from China. Drug Des Dev Ther. 2022;16:3599–3608. doi: 10.2147/DDDT.S378796. - DOI - PMC - PubMed
-
- Corallino D, Balla A, Palmieri L, Sperduti I, Ortenzi M, Guerrieri M, Paganini AM. Is transperitoneal laparoscopic adrenalectomy for pheochromocytoma really more challenging? A propensity score-matched analysis. J Endocrinol Invest. 2023;46(8):1589–1596. doi: 10.1007/s40618-023-02013-7. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
